Effects of Sodium-glucose cotransporters 2 (SGLT2) inhibitors on estimated glomerular filtration rate (eGFR) in randomized controlled trials (RCTs) in patients with type 2 diabetes and chronic kidney disease (CKD) of different levels. Here, SLC5A2 is linked to type 2 diabetes mellitus.